Do pharmacologic, electrical, and surgical interventions reduce mortality in patients with Hypertrophic Cardiomyopathy?
Modern management strategies including pharmacologic, electrical, and surgical interventions have successfully reduced HCM mortality to 0.5% per year.
HCM is the most common genetic disorder of the heart, with 1 case per 200 to 500 persons, and often remains clinically silent. HCM is the most common cause of sudden death in athletes, but pharmacologic, electrical, and surgical interventions have reduced mortality to 0.5% per year.
Barry J. Maron (2018) studied this question.